Literature DB >> 7958855

Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein.

M Hatakeyama1, J A Brill, G R Fink, R A Weinberg.   

Abstract

The retinoblastoma gene product (pRB) constrains cell proliferation by preventing cell-cycle progression from the G1 to S phase. Its growth-inhibitory effects appear to be reversed by hyperphosphorylation occurring during G1. This process is thought to involve G1 cyclins and cyclin-dependent kinases (cdks). Here we report that the cell cycle-dependent phosphorylation of mammalian pRB is faithfully reproduced when it is expressed in Saccharomyces cerevisiae. As is the case in mammalian cells, this phosphorylation requires an intact oncoprotein-binding domain and is inhibited by a negative growth factor, in this case a mating pheromone. Expression of pRB in cln (-) mutants indicates that specific combinations of endogenous G1 cyclins, Cln3 and either Cln1 or Cln2 are required for pRB hyperphosphorylation in yeast. Moreover, expression of mammalian G1 cyclins in cln (-) yeast cells indicates that the functions of Cln2 and Cln3 in pRB hyperphosphorylation can be complemented by human cyclin E and cyclin D1, respectively. These observations suggest a functional heterogeneity among G1 cyclin-cdk complexes and indicate a need for the involvement of multiple G1 cyclins in promoting pRB hyperphosphorylation and resulting cell-cycle progression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7958855     DOI: 10.1101/gad.8.15.1759

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  73 in total

1.  Cumulative effect of phosphorylation of pRB on regulation of E2F activity.

Authors:  V D Brown; R A Phillips; B L Gallie
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  Histone deacetylase-dependent transcriptional repression by pRB in yeast occurs independently of interaction through the LXCXE binding cleft.

Authors:  B K Kennedy; O W Liu; F A Dick; N Dyson; E Harlow; M Vidal
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

Review 3.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

4.  Enhanced expression of cyclins and cyclin-dependent kinases in aniline-induced cell proliferation in rat spleen.

Authors:  Jianling Wang; Gangduo Wang; Huaxian Ma; M Firoze Khan
Journal:  Toxicol Appl Pharmacol       Date:  2010-11-08       Impact factor: 4.219

5.  CtIP activates its own and cyclin D1 promoters via the E2F/RB pathway during G1/S progression.

Authors:  Feng Liu; Wen-Hwa Lee
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

6.  Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins.

Authors:  B E Strober; J L Dunaief; S P Goff
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

7.  Genotoxic stress-induced cyclin D1 phosphorylation and proteolysis are required for genomic stability.

Authors:  Laura L Pontano; Priya Aggarwal; Olena Barbash; Eric J Brown; Craig H Bassing; J Alan Diehl
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

8.  Retinoblastoma protein contains a C-terminal motif that targets it for phosphorylation by cyclin-cdk complexes.

Authors:  P D Adams; X Li; W R Sellers; K B Baker; X Leng; J W Harper; Y Taya; W G Kaelin
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

9.  Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines.

Authors:  W Li; J Fan; D Hochhauser; D Banerjee; Z Zielinski; A Almasan; Y Yin; R Kelly; G M Wahl; J R Bertino
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

10.  Adenovirus E1A specifically blocks SWI/SNF-dependent transcriptional activation.

Authors:  M E Miller; B R Cairns; R S Levinson; K R Yamamoto; D A Engel; M M Smith
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.